A day earlier, it wasn’t mentioned by CEO Yin Weidong in a wide-ranging interview with Bloomberg reporters, and representatives later confirmed the company didn’t know the announcement was coming.
"I respect all the doubts around CoronaVac, that speaks to the attention we are getting, but more important is seeking approval to use the vaccine in a country -- that doesn’t depend on public opinion but the stringent review by authorities,” Yin said in the interview."What do you think is more important than this?”
Given the intense attention, public perception of the safety and strength of vaccines has not only affected whether people will take them, but the actions of governments. AstraZeneca’s vaccine was suspended in a number of European Union countries in March amid anxiety over blood clots, despite the bloc’s medicines regulator saying its benefits outweighed the risk of very rare side effects.
"AstraZeneca was being bashed over the head for giving poor data but you see them trying to explain it.” she said. For Chinese developers,"we just haven’t seen that level of polish and communication around that, which leads everyone to think they must be hiding something.” A WHO expert panel that reviewed Sinovac’s existing data at the end of April said they had a high level of confidence in CoronaVac’s efficacy but there wasn’t enough information to assess the potential for serious side effects in people age 60 or above and those with existing medical conditions.
TITIP INFOIN Nih titik penyekatan di Jabodetabek COvid itu serius bukan bohongan !
Malaysia Latest News, Malaysia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: staronline - 🏆 4. / 75 Read more »
Source: malaymail - 🏆 1. / 86 Read more »
Source: malaysiakini - 🏆 20. / 51 Read more »
Source: staronline - 🏆 4. / 75 Read more »
Source: malaymail - 🏆 1. / 86 Read more »